Bell Rock Capital’s iShares Biotechnology ETF IBB Stock Holding History

Bell Rock Capital’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-375	Closed	-$45K	–	164
2019 Q4	$45K	Sell	375 -96	-20%	-$10.7K	0.04%	225
2019 Q3	$50K	Sell	471 -21	-4%	-$2.2K	0.04%	207
2019 Q2	$54K	Sell	492 -27	-5%	-$2.87K	0.05%	191
2019 Q1	$58K	Sell	519 -241	-32%	-$26.4K	0.03%	221
2018 Q4	$74K	Hold	760	–	–	0.05%	200
2018 Q3	$94K	Sell	760 -170	-18%	-$20K	0.05%	198
2018 Q2	$103K	Sell	930 -894	-49%	-$95.6K	0.05%	187
2018 Q1	$194K	Sell	1,824 -54	-3%	-$5.99K	0.1%	129
2017 Q4	$200K	Buy	1,878 +6	+0.3%	+$641	0.11%	129
2017 Q3	$207K	Buy	1,872 +102	+6%	+$10.9K	0.12%	123
2017 Q2	$189K	Buy	1,770 +117	+7%	+$11.5K	0.12%	123
2017 Q1	$163K	Sell	1,653 -573	-26%	-$54.9K	0.15%	91
2016 Q4	$197K	Buy	+2,226	New	+$203K	0.21%	79

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Bell Rock Capital's IBB Position: Q1 2020 in Review

Bell Rock Capital sold out of iShares Biotechnology ETF (IBB) in Q1 2020, closing a stake of 375 shares — an estimated $45K sold.

Bell Rock Capital first reported a position in IBB in Q4 2016 and held it in 13 quarters. The position peaked at $207K in Q3 2017. 668 funds tracked by Wall St. Rank hold IBB as of Q1 2020.

Bell Rock Capital reported no remaining iShares Biotechnology ETF position as of Q1 2020 after selling out during the quarter.
Bell Rock Capital sold 375 iShares Biotechnology ETF shares in Q1 2020, an estimated $45K.
Bell Rock Capital first reported a position in iShares Biotechnology ETF in Q4 2016 and held it in 13 quarters.
Bell Rock Capital's iShares Biotechnology ETF position peaked at $207K in Q3 2017.
668 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2020.

Based on Bell Rock Capital's 13F filing for Q1 2020, filed 7 May 2020.